Increased cardiovascular risk in subjects with a low prevalence of classic cardiovascular risk factors: The inflammatory bowel disease paradox

Trends in Cardiovascular Medicine

Volumn 25, Issue 8, 2015, Pages 705-706

  Zanoli, Luca ^a   Inserra, Gaetano ^a   Castellino, Pietro ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; C REACTIVE PROTEIN; HOMOCYSTEINE; TRANSFORMING GROWTH FACTOR BETA1;

CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; CROHN DISEASE; EDITORIAL; HUMAN; INFLAMMATORY BOWEL DISEASE; MORBIDITY; PREVALENCE; PRIORITY JOURNAL; PULSE WAVE; ULCERATIVE COLITIS; FEMALE; INFLAMMATORY BOWEL DISEASES; MALE; PATHOPHYSIOLOGY;

CORONARY ARTERY DISEASE; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE;

EID: 84945494357     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2015.04.001     Document Type: Editorial

References (16)

1. Roman M.J., Salmon J.E. Cardiovascular manifestations of rheumatologic diseases. Circulation 2007, 116:2346-2355.
2. Yasmin, McEniery C.M., Wallace S., Mackenzie I.S., Cockcroft J.R., Wilkinson I.B. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol 2004, 24:969-974.
3. Pietri P., Vyssoulis G., Vlachopoulos C., Zervoudaki A., Gialernios T., Aznaouridis K., et al. Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertension. J Hypertens 2006, 24:2231-2238.
4. Booth A.D., Wallace S., McEniery C.M., Yasmin, Brown J., Jayne D.R., et al. Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation. Arthritis Rheum 2004, 50:581-588.
5. Roman M.J., Devereux R.B., Schwartz J.E., Lockshin M.D., Paget S.A., Davis A., et al. Arterial stiffness in chronic inflammatory diseases. Hypertension 2005, 46:194-199.
6. Mäki-Petäjä K.M., Hall F.C., Booth A.D., Wallace S.M., Yasmin, Bearcroft P.W., et al. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-α therapy. Circulation 2006, 114:1185-1192.
7. Rungoe C., Andersen N.N., Jess T. Inflammatory bowel disease and risk of coronary heart disease. Trends Cardiovasc Med 2015, 25:699-704.
8. Geerling B.J., Badart-Smook A., Stockbrugger R.W., Brummer R.J. Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls. Eur J Clin Nutr 2000, 54:514-521.
9. Levy E., Rizwan Y., Thibault L., Lepage G., Brunet S., Bouthillier L., et al. Altered lipid profile, lipoprotein composition, and oxidant and antioxidant status in pediatric Crohn disease. Am J Clin Nutr 2000, 71:807-815.
10. Jahnsen J., Falch J.A., Mowinckel P., Aadland E. Body composition in patients with inflammatory bowel disease: a population-based study. Am J Gastroenterol 2003, 98:1556-1562.
11. Yarur A.J., Deshpande A.R., Pechman D.M., Tamariz L., Abreu M.T., Sussman D.A. Inflammatory bowel disease is associated with an increased incidence of cardiovascular events. Am J Gastroenterol 2011, 106:741-747.
12. Dorn S.D., Sandler R.S. Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysis. Am J Gastroenterol 2007, 102:662-667.
13. Zanoli L., Cannavò M., Rastelli S., Di Pino L., Monte I., Di Gangi M., et al. Arterial stiffness is increased in patients with inflammatory bowel disease. J Hypertens 2012, 30:1775-1781.
14. Zanoli L., Rastelli S., Inserra G., Lentini P., Valvo E., Calcagno E., et al. Increased arterial stiffness in inflammatory bowel diseases is dependent upon inflammation and reduced by immunomodulatory drugs. Atherosclerosis 2014, 234:346-351.
15. Schinzari F., Armuzzi A., De Pascalis B., Mores N., Tesauro M., Melina D., et al. Tumor necrosis factor-α antagonism improves endothelial dysfunction in patients with Crohn's disease. Clin Pharmacol Ther 2008, 83:70-76.
16. Monteleone G., Neurath M.F., Ardizzone S., Di Sabatino A., Fantini M.C., Castiglione F., et al. Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn[U+05F3]s disease. N Engl J Med 2015, 372:1104-1113.